NFX1 inhibitors belong to a distinctive chemical class that plays a pivotal role in the regulation of cellular processes related to nucleic acids. Specifically, they target the NFX1 protein, a multifunctional factor involved in various aspects of RNA metabolism and cellular homeostasis. NFX1, also known as Nuclear Factor-X1, serves as a critical mediator in the maintenance of genomic stability and the control of gene expression. The inhibitors modulate the activity of NFX1 by binding to specific regions on the protein, disrupting its normal function and consequently influencing the intricate network of cellular pathways it regulates.
NFX1 inhibitors is characterized by unique structural motifs that facilitate their interaction with the target protein. These compounds typically exhibit a high degree of specificity for NFX1, selectively inhibiting its activity without significant interference with other cellular components. The development of NFX1 inhibitors has emerged as a promising area of research, contributing to our understanding of fundamental cellular mechanisms and opening avenues for potential applications in various fields. The intricate interplay between NFX1 and its inhibitors offers valuable insights into the intricate orchestration of molecular events within cells, laying the groundwork for further investigations into the broader implications of manipulating this specific cellular pathway.
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Inhibits histone deacetylases leading to changes in chromatin structure, affecting NFX1 activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, altering DNA methylation and possibly affecting NFX1 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can stabilize proteins that regulate NFX1 or its pathway components. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that can alter signaling pathways, potentially modulating NFX1 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK signaling, which may have downstream effects on NFX1 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that could affect pathways regulating NFX1 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which may influence pathways that regulate NFX1 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor that can impact signaling pathways and possibly influence NFX1 function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, which can affect protein synthesis and potentially influence NFX1 activity. |